The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-11-01
著者
-
Kenyon Norma
Diabetes Research Institute Cell Transplant Center University Of Miami
-
Kenyon Norma
Diabetes Research Institute University Of Miami School Of Medicine
-
FERRANT Janine
Biogen Idec, Inc.
-
BENJAMIN Christopher
Biogen Idec, Inc.
-
CUTLER Anne
Biogen Idec, Inc.
-
KALLED Susan
Biogen Idec, Inc.
-
HSU Yen-Ming
Biogen Idec, Inc.
-
GARBER Ellen
Biogen Idec, Inc.
-
HESS Donna
Biogen Idec, Inc.
-
SHAPIRO Renee
Biogen Idec, Inc.
-
HARLAN David
Transplantation and Autoimmunity Branch, National Institute of Diabetes, Digestive and Kidney Diseas
-
KIRK Allan
Transplantation and Autoimmunity Branch, National Institute of Diabetes, Digestive and Kidney Diseas
-
BURKLY Linda
Biogen Idec, Inc.
-
TAYLOR Frederick
Biogen Idec, Inc.
-
Kalled Susan
Biogen Idec Inc.
-
Kirk Allan
Transplantation And Autoimmunity Branch National Institute Of Diabetes Digestive And Kidney Diseases
-
Burkly Linda
Biogen Idec Inc.
-
Harlan David
Transplantation And Autoimmunity Branch National Institute Of Diabetes Digestive And Kidney Diseases
-
Shapiro Renee
Biogen Idec Inc.
-
Ferrant Janine
Biogen Idec Inc.
-
Hsu Yen-ming
Biogen Idec Inc.
-
Garber Ellen
Biogen Idec Inc.
-
Hess Donna
Biogen Idec Inc.
-
Benjamin Christopher
Biogen Idec Inc.
-
Taylor Frederick
Biogen Idec Inc.
-
Cutler Anne
Biogen Idec Inc.
関連論文
- INSULIN A CHAIN 1-15 RECOGNIZED BY EXPANDED T CELLS FROM HUMAN TYPE 1 DIABETIC PANCREATIC DRAINING LYMPH NODES
- The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge